Guardant Health (GH) director sells 116 shares after RSU conversion
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Guardant Health director Tariq Musa reported routine equity activity tied to a prior restricted stock unit (RSU) grant. On April 15, 2026, he exercised 250 Restricted Stock Units at $0.00, converting them into 250 shares of Common Stock. On April 16, 2026, he completed an open-market sale of 116 Common Stock shares at an average price of $84.83 per share.
Following these transactions, Musa directly holds 8,528 shares of Common Stock and 2,749 Restricted Stock Units. The RSU award, granted on March 6, 2023, vests over four years, with 25% vesting on March 15, 2024 and the remaining 75% vesting monthly over the next three years.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 116 shares ($9,840)
Net Sell
3 txns
Insider
Tariq Musa
Role
Director
Sold
116 shs ($10K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 116 | $84.83 | $10K |
| Exercise | Restricted Stock Units | 250 | $0.00 | -- |
| Exercise | Common Stock | 250 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 8,528 shares (Direct);
Restricted Stock Units — 2,749 shares (Direct)
Footnotes (1)
- The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2024 and the remaining 75% vests monthly for the three-year period thereafter. Not applicable for Restricted Stock Units.
Key Figures
Shares sold: 116 shares
Sale price: $84.83 per share
RSUs exercised: 250 units
+4 more
7 metrics
Shares sold
116 shares
Open-market sale of Common Stock on April 16, 2026
Sale price
$84.83 per share
Average price for 116-share sale on April 16, 2026
RSUs exercised
250 units
Restricted Stock Units converted to Common Stock on April 15, 2026
Common shares held
8,528 shares
Direct Common Stock holdings after transactions
RSUs outstanding
2,749 units
Restricted Stock Units remaining after April 15, 2026 exercise
Initial RSU vesting
25% on March 15, 2024
First tranche of March 6, 2023 RSU grant
Remaining RSU vesting
75% over three years
Monthly vesting following March 15, 2024
Key Terms
Restricted Stock Units, open-market sale, derivative exercise/conversion
3 terms
Restricted Stock Units financial
"The restricted stock unit award granted on March 6, 2023 vests over a four-year period."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
FAQ
What insider transactions did Tariq Musa report for Guardant Health (GH)?
Director Tariq Musa exercised 250 Restricted Stock Units into Common Stock and then sold 116 Common Stock shares in an open-market transaction at $84.83 per share, reflecting routine equity compensation activity.
What was the size of Tariq Musa’s RSU exercise in Guardant Health stock?
He exercised 250 Restricted Stock Units, converting them into 250 shares of Common Stock at a $0.00 exercise price. This RSU activity is part of a longer four-year vesting schedule from a prior equity grant.
How do Tariq Musa’s Restricted Stock Units in Guardant Health vest over time?
The RSU award granted on March 6, 2023 vests over four years: 25% vested on March 15, 2024, and the remaining 75% vests in monthly installments over the following three-year period.